Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
02/27/2013
Trade Name:
Intelence
Generic Name or Proper Name (*):
etravirine
Indications Studied:
Postmarketing study
Label Changes Summary:
Information on 48 week safetyThe safety profile for patients who completed 48 weeks of treatment was similar to the safety profile for patients who completed 24 weeks of treatmentPostmarketing study
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Janssen
NNPS:
TRUE'
Therapeutic Category:
Antiviral
-
-